The Yangtze Delta Drug Advanced Research Institute in Haimen district, Nantong, Jiangsu province has been listed as a provincial technology enterprise incubator, as recently announced by the Jiangsu Provincial Department of Science and Technology.

The research institute focuses on incubating new candidate drugs for major diseases such as malignant tumors, metabolic disorders, cardiovascular diseases, immune disorders, and neurological and psychiatric disorders.

It has also set up a comprehensive technology platform for the entire chain of drug discovery, preclinical research, clinical research, and production.

The research institute has established ties with universities and research institutes to achieve in-depth integration of the innovation chain, talent chain, industrial chain, and capital chain.

The research institute has also pioneered a new model for cultivating high-caliber talent in the biopharmaceutical industry in which it encourages students to actively participate in practical activities such as production and management in the medical field.